Acute Ischemic Stroke clinical trials in Texas
13 active Acute Ischemic Stroke trials with a site in Texas. Describe your situation to see which ones look like a fit.
- A Study of TAK-755 in Adults With Acute Ischemic Stroke
- Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well
- Optimizing Reperfusion to Improve Outcomes and Neurologic Function
- Safety and Efficacy of J147 in Acute Ischemic Stroke
- The Pivotal Study of RapidPulseTM Aspiration System
- Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
- Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
- Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
- REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)
- Balloon Guide Versus Conventional Guide Catheter in Stroke Thrombectomy
- Virtually Assisted Home Rehabilitation After Stroke for Underserved Texas Communities
- Safety Of A Second Dose Of Tenecteplase In Selected Acute Ischemic Stroke Patients Not Responding To The First Dose
- Reduce Inefficiencies in Management of Spasticity
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.